Investors continue to be optimistic about BSX, courtesy of its international expansion efforts and WATCHMAN's performance.

Looking back, Kokomo resident Mike Beatty knew he had something as a teenager, but he couldn’t put a name to it.

Boston Scientific Corporation BSX remains in the spotlight, with its stock currently trading close to its 52-week high. In the past six trading sessions, the stock has consistently traded above $90.00 ...

Boston Scientific closes the year at historic highs, with investors refusing to liquidate even at these levels. Check out why ...

Boston Scientific is part of the Health Care sector, which has an average P/E ratio of 26.07 and an average P/B of 3.53 BSX has reported YOY quarterly earnings growth of -6.3% and gross profit margins ...

The BD Medical segment provides peripheral intravenous ... and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable ...

However, their website also states certain people — like those who cannot take medication like warfarin or aspirin — are not candidates for the WATCHMAN device. Another treatment that just ...

Sweden’s night watchman is just one of the handful of “cultural marvels on the edge of disappearance” that Stein documents in “Custodians of Wonder.” He travels to the mountains of Italy ...

Medical-device maker Stryker on Monday agreed to acquire Inari Medical , which makes devices that treat patients with venous ...